Tevogen (TVGN) Revenue (2023 - 2026)
Powered by 
Analysis
Tevogen (TVGN) Revenue (2023 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 22.97 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 25.40 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 16.99 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 16.61 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 14.41 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 15.38 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 10.05 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 7.80 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 15.03 Bn |
| 10 | Tevogen | 27.79 Mn | 27.79 Mn | - | -98,387.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -98,387.00 |
| Mar 31, 2026 | -71,166.00 |
| Dec 31, 2025 | -70,674.00 |
| Sep 30, 2025 | -62,340.00 |
| Jun 30, 2025 | -38,033.00 |
| Mar 31, 2025 | -24,571.00 |
| Dec 31, 2024 | -15,798.00 |
| Sep 30, 2024 | -12,459.00 |
| Jun 30, 2024 | 6.00 |
| Jun 30, 2023 | -299,887.00 |
API Access
Tevogen Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=TVGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "TVGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=TVGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();